![ECCO Medical on Twitter: "First Auryon Laser Atherectomy in Colorado done today at ECCO. Complete occlusion of viabahn stent in SFA with development of wound. Treated with 2.0mm catheter with aspiration f(x). . . . . # ECCO Medical on Twitter: "First Auryon Laser Atherectomy in Colorado done today at ECCO. Complete occlusion of viabahn stent in SFA with development of wound. Treated with 2.0mm catheter with aspiration f(x). . . . . #](https://pbs.twimg.com/media/ETbVPftUUAAGW7y.jpg:large)
ECCO Medical on Twitter: "First Auryon Laser Atherectomy in Colorado done today at ECCO. Complete occlusion of viabahn stent in SFA with development of wound. Treated with 2.0mm catheter with aspiration f(x). . . . . #
![FBW-1.5/2 WITH LASER ENGRAVING AND MATTE BRASS PLATE AND BLACK SUBLIMATION - Moslow Wood Products (Virginia) FBW-1.5/2 WITH LASER ENGRAVING AND MATTE BRASS PLATE AND BLACK SUBLIMATION - Moslow Wood Products (Virginia)](https://moslowwood.com/wp-content/uploads/2015/04/DSC_0022.jpg)
FBW-1.5/2 WITH LASER ENGRAVING AND MATTE BRASS PLATE AND BLACK SUBLIMATION - Moslow Wood Products (Virginia)
![Atherectomy using a solid‐state laser at 355 nm wavelength - Herzog - 2017 - Journal of Biophotonics - Wiley Online Library Atherectomy using a solid‐state laser at 355 nm wavelength - Herzog - 2017 - Journal of Biophotonics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1f375c74-dc95-473c-ba20-4a47225ad7b5/jbio201600209-fig-0002-m.jpg)
Atherectomy using a solid‐state laser at 355 nm wavelength - Herzog - 2017 - Journal of Biophotonics - Wiley Online Library
![Eximo Medical's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile Eximo Medical's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/eximo-medical_owler_20190621_002112_original.jpg)
Eximo Medical's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![CRT-200.06 Acute and 30-Day Safety and Effectiveness Evaluation of Eximo Medical's B-Laser, a Novel Atherectomy Device, in Subjects Affected With Infrainguinal Peripheral Arterial Disease: Results of the EX-PAD-03 Trial | JACC: Cardiovascular CRT-200.06 Acute and 30-Day Safety and Effectiveness Evaluation of Eximo Medical's B-Laser, a Novel Atherectomy Device, in Subjects Affected With Infrainguinal Peripheral Arterial Disease: Results of the EX-PAD-03 Trial | JACC: Cardiovascular](https://www.jacc.org/cms/asset/9f1b027b-dd63-4663-b334-8177b509393e/j.jcin.2019.01.095.fp.png)
CRT-200.06 Acute and 30-Day Safety and Effectiveness Evaluation of Eximo Medical's B-Laser, a Novel Atherectomy Device, in Subjects Affected With Infrainguinal Peripheral Arterial Disease: Results of the EX-PAD-03 Trial | JACC: Cardiovascular
![Eximo Medical receives FDA clearance for B-Laser atherectomy system to treat peripheral arterial disease Eximo Medical receives FDA clearance for B-Laser atherectomy system to treat peripheral arterial disease](https://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/10/eximo-medical-7x4-e1539272264648.jpg)
Eximo Medical receives FDA clearance for B-Laser atherectomy system to treat peripheral arterial disease
![Treatment of Totally Occluded Popliteal Artery With the Auryon Laser Via Pedal Access in a Patient With Chronic Limb-Threatening Ischemia Treatment of Totally Occluded Popliteal Artery With the Auryon Laser Via Pedal Access in a Patient With Chronic Limb-Threatening Ischemia](https://d148x66490prkv.cloudfront.net/hmp_ln/inline-images/Shammas%20Popliteal%20Artery%20Figure%203.png?VersionId=kUd6kq3JwobNWbwpuUL3cM9dJ_HZpTyH)